At a glance
ClinicalIndex Comparison RecordN/ACompleted· 260 enrolled
Drug / intervention
e-Health (web-based) disclosure portal +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Protocol Evaluating Return of Actionable Genetic Research Results to Biobank Participants
In Brief
A clinical study evaluating e-Health (web-based) disclosure portal and Provider mediated disclosure for Cancer and 3 related conditions. Completed, enrolled 260 participants across 1 site.
Detailed Summary
The overall goal of the proposed research is to assess the feasibility of a randomized study evaluating the non-inferiority of an electronic Health (e-Health) delivery alternative (e.g. private web portal) as compared to return of actionable genetic research results with a genetic counselor.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsFox Chase Cancer Center
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJan 2020
Enrollment StartMar 2020
Primary CompletionApr 2023
Study CompletionAug 2023
TodayJul 2026
First PostedJan 27, 2020
Enrollment StartMar 1, 2020
Primary CompletionApr 11, 2023
Study CompletionAug 1, 2023
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 6.4 years ago
Interventions
e-Health (web-based) disclosure portalbehavioral
Patient uses secure web-based portal to access genetic research results
Provider mediated disclosurebehavioral
Patient has disclosure of genetic research result by a provider (genetic counselor)